Clinical Trials Directory

Trials / Completed

CompletedNCT00434876

The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence

The Effects of Quetiapine on Sleep During Alcohol Abstinence

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Subhajit Chakravorty · Federal
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to determine how efficacy of quetiapine (seroquel XR) in improving the sleep in recovering alcohol dependent subjects.

Detailed description

Sober alcohol dependent subjects frequently complain of difficulty falling asleep as well as staying asleep which may eventually lead to relapse. Novel antipsychotic medications such as quetiapine have shown some efficacy in treating alcoholism and have also shown some benefit in improving insomnia. The primary aim of this study is to determine the degree to which quetiapine improves sleep in veterans during the early phase of recovery from alcohol dependence. The sleep efficiency from an in-lab polysomnogram will be the primary outcome measure. Secondary measures of sleep will include the Pittsburgh Sleep Quality Index, Insomnia Severity Index, and actigraphy. Other additional aims will explore for alcohol use and cravings, change in psychiatric symptoms using the The Time Line Follow Back measure, Penn Alcohol Craving Scale (PACS), the Patient Health Questionnaire-9 item scale (PHQ-9), and the Beck's Anxiety Inventory (BAI) respectively. Twenty four subjects within the first year of sobriety will be enrolled. Participants will be undergo an extensive baseline screening procedure. After 2 consecutive in-laboratory polysomnograms they will be treated with either Quetiapine XR or matching placebo pills targetting a dose of 400 mg a night. The treatment duration will be 8 weeks and during the eight week of treatment they will undergo 2 more nights of in-laboratory polysomnogram. All subjects will also receive Medical Management therapy, a standardized psychosocial intervention which is medically-based and focusses on alcohol abstinence and medication compliance.

Conditions

Interventions

TypeNameDescription
DRUGQuetiapine XRQuetiapine is a second generation antipsychotic medication, which has also recently shown to be associated with properties of mood stabilization in bipolar disorder.
DRUGPlacebo.Inactive or inert pill which will be used as a comparator.

Timeline

Start date
2007-08-01
Primary completion
2009-11-01
Completion
2009-12-01
First posted
2007-02-14
Last updated
2013-08-09
Results posted
2013-08-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00434876. Inclusion in this directory is not an endorsement.